Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Cayman
AZD 7986
132
CHF
CHF 132.00
In stock
CAY-33184-11 mgCHF 132.00
CAY-33184-55 mgCHF 422.00
CAY-33184-1010 mgCHF 775.00
CAY-33184-2525 mgCHF 1'291.00
Product Details | |
---|---|
Synonyms | Brensocatib; INS1007 |
Product Type | Chemical |
Properties | |
Formula | C23H24N4O4 |
MW | 420.5 |
CAS | 1802148-05-5 |
Purity Chemicals | ≥98% |
Appearance | A solid |
Declaration | Manufactured by Cayman Chemicals. |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
InChi Key | AEXFXNFMSAAELR-RXVVDRJESA-N |
Smiles | CN1C2=CC(C3=CC=C(C=C3)C[C@@H](C#N)NC([C@@H]4CNCCCO4)=O)=CC=C2OC1=O |
Shipping and Handling | |
Shipping | BLUE ICE |
Long Term Storage | -20°C |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
An inhibitor of DPP-1 (IC50 = 3.9 nM); selective for DPP-1 over cathepsins S, -L, -B, -K, -D, -E, -Z, -H, and -G (IC50s = >20 µM for all), as well as a panel of >200 enzymes, receptors, ion channels, and transporters; inhibits activation of neutrophil elastase, proteinase 3, and cathepsin G in human bone marrow-derived CD34+ neutrophil progenitor cells (IC50s = 61.7, 208.9, and 114.8 nM, respectively); inhibits activation of neutrophil elastase and proteinase 3 in rat bone marrow lysates at 0.2, 2, and 20 mg/kg; suppresses NET formation, increases survival, and reduces the number of lung metastases in a 4T1 murine mammary carcinoma model.